The potential of immunomodulatory drugs in the treatment of solid tumors

By Dalgleish Angus   Galustian Christine  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1479-1484

Future Medicine

Access to resources Recommend Favorite

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug–drug interaction potential

By LoRusso Patricia   Piha-Paul Sarina   Mita Monica   Colevas A.   Malhi Vikram   Colburn Dawn   Yin Ming   Low Jennifer   Graham Richard  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 193-202

Springer Publishing Company

Access to resources Recommend Favorite

New Treatment Options for Patients with Advanced Neuroendocrine Tumors

By Chan Jennifer  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 136-148

Springer Publishing Company

Access to resources Recommend Favorite

Treatment resistance of solid tumors: Role of hypoxia and anemia

By Vaupel Peter   Thews Oliver   Hoeckel Michael  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 243-259

Humana Press, Inc

Access to resources Recommend Favorite

Use of PEG-asparaginase in the treatment of patients with solid tumors

By Pinheiro João   Lanvers Claudia   Boos Joachim  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 421-422

Springer Publishing Company

Access to resources Recommend Favorite